Patel Ronil A. 4
4 · Ocuphire Pharma, Inc. · Filed Jan 12, 2024
Insider Transaction Report
Form 4
Patel Ronil A.
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2024-01-10$3.27/sh−1,282$4,186→ 90,714 total
4 · Ocuphire Pharma, Inc. · Filed Jan 12, 2024
Common Stock